Is water-laser treatment worth it? Costs and drawbacks

Is water-laser treatment worth it? Costs and drawbacks

Direct answer in 60 words

There is no single answer: it depends on the use. Studies record fewer people needing anaesthesia for caries removal, but longer treatment time and low-certainty evidence [F7]; for periodontal adjunctive use, the European guideline suggests not using lasers [F10]. A dentist must assess the individual situation.

Geographic scope: This guide is specific to Taiwan's healthcare system (National Health Insurance and Taiwan's Medical Care Act). Mechanism and clinical-evidence passages cite international literature and guidelines and are tagged `geo: universal` in each F-Unit. Institutional, coverage and fee passages are tagged `geo: TW`. For the official English text of Taiwan's Medical Care Act, see https://law.moj.gov.tw/ENG/LawClass/LawAll.aspx?pcode=L0020021 .

First separate the question: “water laser” is a device, not a treatment

People searching for water-laser drawbacks, scaling or cost are usually asking what an extra charge buys. “Worth it” cannot answer that, because the same device can be used for caries removal, periodontal treatment, soft-tissue surgery, peri-implantitis and dentine hypersensitivity. The literature gives different answers, with very different certainty, for those clinical questions.[F6][F7][F10][F19][F20][F21]

This card therefore asks three verifiable questions: what the device mechanism is, what the literature says for the particular intended use, and how strong that evidence is. This is the site's editorial framework, not a diagnostic tool.[F2]

Scope boundary: the full discussion of water-laser use for gingival recession and root coverage belongs to KM-DENTAL-27. This card gives only a short signpost; see the internal citation chain below.

The name itself has two ambiguities

• In the literature, the erbium-family lasers described as highly absorbed by water and hydroxyapatite, enabling precise ablation with less thermal diffusion and collateral damage, are Er:YAG (erbium-doped yttrium aluminium garnet) and Er,Cr:YSGG (erbium, chromium: yttrium-scandium-gallium-garnet).[F4][F6] This card uses the English abbreviations. Taiwan licence names use at least three Chinese renderings for the same family, with 10, 8 and 3 licences after deduplication, so the Chinese name alone cannot identify the device.[F5]
• They are not the same wavelength. A 2023 systematic review lists Nd:YAG at 1064 nm, Er:YAG at 2940 nm, Er,Cr:YSGG at 2780 nm, diode at 980 nm and CO2 at 10600 nm.[F3] The European Federation of Periodontology (EFP) guideline analyses periodontal lasers in two wavelength groups: 2780 to 2940 nm and 810 to 980 nm.[F11]
• The Chinese term “water laser” is not a literature or regulatory device category. In the TFDA licence dataset, only 2 deduplicated licences have that string in the Chinese product name; the 1 current, non-cancelled entry identifies an Er:YAG system in English.[F5] This only shows that the term is not a conventional official product name. It does not show that only two machines are licensed: dental lasers are often registered by brand, and this was a product-name string search, not a device list.[F5]

Accordingly, the name alone cannot tell you the wavelength or which evidence base applies. This is why Er:YAG and Er,Cr:YSGG are kept separate rather than merged.[F3][F5][F11]

This card does not state authorised indications for any model

Dental lasers in Taiwan are medical devices requiring a licence. In the same official dataset, a product-name search found 54 deduplicated dental-related licences containing “laser”; 17 were not cancelled. All 17 performance fields say to see the approved Chinese instructions for use or approved Chinese manual, rather than giving the authorised performance range in the public field.[F5] This is a string-search result, not a complete list of Taiwan dental-laser models, and cannot establish that any brand or wavelength lacks a licence.[F5]

This card therefore makes no statement about the authorised indication or performance of any device. Ask the provider for the licence number and check the licence and Chinese instructions for use. Of the 17 current entries, only 4 name the laser type in the product name and 13 do not—another reason the name is insufficient.[F5]

1. What the literature says for each use

Caries removal and cavity preparation: a consistent direction, but low-certainty evidence and longer time

• The 2016 Cochrane review included 9 randomised trials and 662 participants: 6 used Er:YAG, 2 Er,Cr:YSGG and 1 Nd:YAG. For caries removal, it found insufficient evidence that either laser or drill was better.[F6]
• In that review, moderate or high pain was more frequent in the drill group (risk ratio 0.40, 95% confidence interval 0.28 to 0.57; 2 studies, 143 participants), and the need for anaesthesia was significantly higher with drills (risk ratio 0.25, 95% confidence interval 0.10 to 0.65; 3 studies, 217 children/adolescents). With low overall evidence quality, it did not support laser as a replacement for a conventional drill.[F6]
• A 2025 meta-analysis of 20 in-vivo studies, at least 2263 teeth and more than 1090 patients found no significant laser-related difference in restoration survival (risk ratio 1.51, 95% confidence interval 0.87 to 2.64) or pulp vitality (risk ratio 1.46, 0.33 to 6.46). Fewer patients required anaesthesia (risk ratio 0.29, 0.11 to 0.75) and pain was lower (risk ratio 0.35, 0.22 to 0.54), but laser excavation/preparation required more scheduled time (mean difference 2.23, 95% confidence interval 1.89 to 2.57).[F7]
• The indispensable qualification is that the five outcomes above were rated low or very low certainty; anaesthesia and pain were very low certainty, and the authors said results should be interpreted cautiously.[F7]
• A 2026 review of 11 studies (5 in vitro and 6 in vivo) recorded that most studies found Er:YAG and Er,Cr:YSGG capable of caries removal and selective ablation of infected dentine, whereas Nd:YAG had lower ablation efficiency. Laser treatment generally took longer than rotary instruments but caused less pain and anxiety in clinical studies; heterogeneity prevented meta-analysis. It called for well-designed randomised trials because of methodological variation, limited Er,Cr:YSGG and Nd:YAG evidence and lack of long-term outcomes.[F8]
• The World Federation for Laser Dentistry (WFLD) 2025 consensus describes laser-assisted caries removal as a minimally invasive, selective-ablation approach and records the water/hydroxyapatite absorption of erbium lasers.[F4][F9] Its issuer is a laser-dentistry professional federation, so its orientation can be expected to favour laser applications; its evidence base mixes in-vitro, ex-vivo and clinical research.[F9]

Periodontal treatment: the guideline direction is “do not use”

• The EFP S3 clinical-practice guideline for stage I to III periodontitis states: “We suggest not to use lasers as adjuncts to subgingival instrumentation.”[F10]
• The evidence behind that recommendation is small: 5 randomised trials, 147 participants in total, at least 6 months of follow-up and a single laser application.[F11] Studies differed in laser type, tip diameter, wavelength, periodontal-treatment mode, number of treated sites and population; the guideline says evidence is insufficient to recommend adjunctive laser use for subgingival instrumentation.[F10][F28]
• This guideline has a Taiwan connection: the 2021 Taiwan Academy of Periodontology consensus developed recommendations for the Taiwanese population from the EFP S3 guideline. It says the recommendations are generally parallel and can be adopted for periodontal treatment and periodontal-health maintenance in the Taiwanese population, while Asian anatomical variations require extra caution during treatment and maintenance.[F15]
• A 2021 Er,Cr:YSGG meta-analysis of 16 randomised trials and 606 patients found statistically significant differences in periodontal-pocket depth at 1 month and 3 months, and in visual-analogue pain immediately after treatment; at 6 months, changes in pocket depth and clinical attachment level were not statistically significant.[F16]
• A 2026 systematic review and meta-analysis covering 2015 to 2025 qualitatively synthesised 26 studies, but only Er:YAG had enough data for quantitative pooling. The pooled clinical-attachment gain was mean difference 0.319 mm (95% confidence interval −0.097 to 0.735), not statistically significant, with I² about 54%. It calls the possible additional benefit small, Er:YAG relatively consistent but clinically limited, and supplementary rather than routine.[F17]
• A 2024 umbrella review of Er:YAG found only 4 eligible systematic reviews, with methods from high to critically low quality, and concluded that clinical benefits remain lacking despite weak evidence of effectiveness.[F18]
• For replacing ordinary professional cleaning, the EFP separately suggests not replacing conventional professional mechanical plaque removal in supportive periodontal care with an alternative method, Er:YAG laser treatment.[F14]

Evidence is not one-sided: a network meta-analysis reports the opposite direction

The 2022 network meta-analysis included 37 randomised trials and 7 periodontal interventions, searching to January 2020. At 6 months versus mechanical scaling and root planing, Er,Cr:YSGG as an adjunct (standardised mean difference 0.53, 95% confidence interval 0.23 to 0.84) and as monotherapy (0.37, 0.04 to 0.71) had statistically significant pocket-depth reductions; its conclusion favoured laser-assisted periodontal treatment for pocket-depth reduction.[F29]

This conflicts with the Er,Cr:YSGG-specific paired meta-analysis even though their searches both ended in January 2020 and their author groups partly overlap. One uses direct paired comparisons and weighted mean differences; the other uses indirect network comparisons and standardised mean differences. Different synthesis methods can therefore give different significance results from the same trials—an indication that the evidence is not stable.[F16][F29] The EFP recommendation also has a defined scope: only randomised trials reporting mean pocket-depth change were included, and most had unclear risk of bias.[F11]

The honest reading is: short-term outcomes (1 to 3 months of pocket depth and immediate pain) may differ [F16]; at 6 months, the paired Er,Cr:YSGG analysis found no significant difference while the network analysis found one [F16][F29]; the 2026 all-laser meta-analysis did not reach statistical significance for its primary result [F17]; and the guideline direction is not to use lasers.[F10][F14] The conclusion is not “lasers do not work”, but that different synthesis methods yield inconsistent conclusions and the current guideline chooses a conservative recommendation under that uncertainty. A dentist should assess the individual case rather than an article deciding it.

Peri-implantitis: inflammatory measures may improve, but not better than conventional care

The 2025 systematic review and meta-analysis included 15 randomised trials, 540 patients and 658 implants (10 in the meta-analysis). Er:YAG reduced bleeding on probing by 35.6% (95% confidence interval 17.3% to 53.9%, I² = 83%) and probing depth by 0.65 mm (0.33 to 0.97, I² = 0%); mechanical debridement plus Er,Cr:YSGG improved probing depth by 1.23 mm (0.76 to 1.70, I² = 0%) and reduced bleeding on probing by 47.3% (38.4% to 56.1%, I² = 0%).[F19] But no therapy had a significant advantage in preventing crestal bone loss, and laser therapies did not demonstrate significant superiority over conventional therapies (p > 0.05).[F19]

Soft-tissue surgery, such as upper-labial-frenulum treatment: favourable direction, no identifiable best laser

The 2023 systematic review of upper labial frenulum surgery included only 8 articles. It reports intra- and postoperative advantages of laser surgery over a conventional scalpel—faster healing, fewer side effects and discomfort, and greater patient compliance—but also a higher learning curve, especially for calibrating appropriate laser power. It says no laser type can yet be identified as achieving the best clinical results for this surgery.[F20] Thus the evidence supports lasers as a tool class for this application, not a particular wavelength or machine.[F20]

Dentine hypersensitivity and gingival recession: signpost only; the canonical card is elsewhere

For Er,Cr:YSGG and dentine hypersensitivity, a 2022 review included 7 randomised trials, searched to March 2022 and used 2780 nm, 0.25 to 0.5 watts, and 20 to 60 seconds, with follow-up from immediate to 3 months. It reports all included studies found relief of dentine hypersensitivity and says adverse effects may be limited with appropriate parameters.[F21] Its limitations remain 7 studies, at most 3 months' follow-up, no meta-analysis and 2 published correction notices.[F21] The complete comparison is in KM-DENTAL-27.[F2]

For gingival recession and root coverage, KM-DENTAL-27 has already addressed the evidence line by line: laser combined with flap grafting did not add root-coverage or aesthetic benefit in meta-analysis, while water-laser evidence itself comes from small single-centre trials. This card does not repeat it.[F2]

2. Drawbacks and limits

1. Time is quantified in meta-analysis: laser caries excavation and cavity preparation required more scheduled time (mean difference 2.23, 95% confidence interval 1.89 to 2.57), and the 2026 review likewise records longer time than rotary instruments.[F7][F8]
2. Evidence certainty is low: caries-removal benefits were rated low and very low certainty; Cochrane rated overall evidence low; and the Er:YAG umbrella review found weak evidence with insufficient clinical benefit.[F6][F7][F18]
3. Guidelines are conservative: the EFP suggests against adjunctive lasers for subgingival instrumentation and against replacing conventional professional mechanical plaque removal with Er:YAG.[F10][F14] Read this alongside the conflict above: the network meta-analysis reports an opposite 6-month direction, while the guideline rests on 5 single-application trials considering only pocket depth.[F11][F29]
4. Adverse-event data are incomplete: most studies did not report potential harm or adverse effects. No report is a data gap, not proof of safety.[F13]
5. Parameters and operator differences recur: studies vary in laser type, tip diameter, wavelength, treatment mode, sites and population; the 2026 FDI-linked review says outcomes vary with wavelength, energy settings and clinical protocols, requiring standardisation; the soft-tissue review names power calibration and the learning curve.[F20][F23][F28]
6. Wavelengths do not act alike on tissues: a review of 57 in-vitro/ex-vivo studies records vitreous surfaces, carbonisation and cracks with Nd:YAG; irregular surfaces without adverse thermal effects with other lasers; and collagen-matrix reduction only with Er,Cr:YSGG, becoming more pronounced at higher dosimetry.[F22] These are not clinical outcomes, but show that “laser” is not a uniform exposure.
7. Not every situation is suitable, and a patient cannot determine this alone: this card did not obtain a citable, verifiable dental-laser contraindication list and therefore does not invent one. Suitability, laser type and parameters require a dentist's assessment of general health and oral conditions.[F13][F23]
8. There can be an extra fee: the EFP economic-considerations field says additional costs associated with adjunctive laser therapy may not be justified. This is a guideline judgement on the evidence base, not an evaluation of any provider's charge.[F12]

Risk factors: indications, possible adverse effects and contraindications

• Indications: for dental lasers, authorised performance is defined by the particular device's licence and Chinese instructions for use. For the current licences found here, the public performance field directs readers to those documents rather than publishing specific indications.[F5] A dentist must assess individual suitability.
• Possible adverse effects: the guideline-level source says most periodontal-laser studies did not report potential harms/adverse effects.[F13] In-vitro/ex-vivo evidence records wavelength-dependent morphological and chemical effects on dentine, including thermal-damage changes and collagen-matrix reduction that become stronger with higher dosage.[F22] The treating dentist must explain actual risks for the model, parameters and tissue situation.
• Contraindications: no citable, locally verifiable contraindication list was obtained while producing this card, so none is listed or filled in by inference.[F2] Ask the dentist directly before treatment.
• Shared premise: all evidence above is population-level research, not a prediction for an individual tooth. Treatment and outcomes vary by person and require dental assessment.

3. How to read cost without quoting an amount

What makes up the fee

1. The base treatment: first identify whether the treatment is caries removal, periodontal treatment or soft-tissue surgery. Its billing structure and whether it is in the National Health Insurance scope determine the base component.[F24]
2. Whether device assistance is a separate charge: laser assistance may be listed separately. Ask whether to add it, and which outcome measure the extra charge is intended to improve, against the evidence direction and certainty above.[F7][F10][F17]
3. Time: studies record longer laser procedure time, so visit scheduling and the number of return visits may differ.[F7][F8]
4. The same name is not the same intervention: different wavelengths, parameters and indications may all be called “water laser”. An identical line-item name does not establish identical content.[F3][F5][F11]

National Health Insurance and self-pay: Taiwan's system

• In the current National Health Insurance Administration Medical Service Payment Items and Payment Standards data, dental-calculus removal has local and full-mouth items. Its note says that patients with treatment needs may claim at most once every 6 months; staged local calculus removal within 6 months is treated as one course; and calculus removal requires oral-hygiene instruction followed by tooth-brushing review.[F24] Separate calculus-removal items have their own claim-interval rules for pregnant women, people with diabetes, people with high-risk diseases and people with xerostomia.[F24]
• In other words, National Health Insurance covers the dental-calculus-removal treatment item; the item name and claim conditions can be checked directly.[F24] Whether device assistance is separately self-paid and which item it is under depends on the provider's properly disclosed charge items and the written quotation. This card makes no determination.
• Self-pay fee standards are approved by local health authorities. A verified example is the Taipei City Department of Health's “Taipei City Medical Institution Dental Fee Standard Table” (approved 1090117), whose page supplies the approved file. Other counties/cities have their own health-authority fee-standard notices.[F25]

Three verification routes you can take yourself

1. The dental fee standard approved by the health authority in the county/city of treatment: check how the intended item is approved locally.[F25]
2. Ask the provider for an itemised written quotation: list the base treatment separately from any device-assistance surcharge, and ask which outcome measure the surcharge is intended to improve.[F7][F10]
3. TFDA Medical Device Licence Dataset: after asking the provider for the model's licence number, check the licence number, Chinese and English product names and cancellation status. The dataset is provided by the Food and Drug Administration, updated every 7 days, and includes licence number, cancellation status, validity dates, Chinese and English names, performance and restriction fields.[F5] The performance field commonly directs readers to the approved Chinese instructions for use.[F5]

One commonly suggested route must be excluded: the National Health Insurance Administration's medical-device price-comparison site has no dental category in either of its category lists, so it cannot verify dental self-pay items.[F26]

Checklist before the visit: take these 7 questions

1. Which clinical problem is being treated—caries, periodontal disease, soft tissue, peri-implant condition or hypersensitivity—and what is the conventional approach?[F2]
2. If laser assistance is added, which outcome measure is expected to change? Is it a short-term measure or one at 6 months or later?[F16][F17]
3. What laser type and wavelength is this machine, and what is its licence number?[F3][F5]
4. How does the authorised performance range read in the instructions for use? May I see it?[F5]
5. Will laser use change this treatment's time or number of return visits?[F7][F8]
6. What is the non-laser approach, and what is the difference for my situation?[F10][F14]
7. How is the fee divided? Which items are the base treatment and device assistance? May I have an itemised written quotation?[F25]

Every clinical statement in this article is mapped line by line to its cited source (see the sources and evidence chain below). It has not been clinically reviewed by a licensed practitioner. This is health information, not individual advice; assessment by a clinician is required.